Karyopharm Therapeutics (KPTI) Q2 2023 Earnings Call Transcript
Karyopharm Therapeutics (NASDAQ: KPTI)
Q2 2023 Earnings Call
Aug 02, 2023, 8:00 a.m. ET
Operator
Source Fool.com
Karyopharm Therapeutics Inc. Stock
€0.99
5.900%
We see a rather positive sentiment for Karyopharm Therapeutics Inc. with 7 Buy predictions and 2 Sell predictions.
With a target price of 6 € there is potential for a 506.06% increase which would mean more than doubling the current price of 0.99 € for Karyopharm Therapeutics Inc..